Home > Insider Trading > Filing (0001181431-15-007118)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1478242	Quintiles Transnational Holdings Inc.	Q	Services-Commercial Physical & Biological Research (8731)	271341991

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
939158	D Ph B Dennis Gillings	C/O Quintiles Transnational Holdings Inc 4820 Emperor Blvd. Durham NC 27703	Executive Chairman	Yes	Yes	Yes	No
1576135	Partnership Limited Gfef	C/O Quintiles Transnational Holdings Inc 4820 Emperor Blvd. Durham NC 27703		No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2015-05-19	500,000	$13.06	13,505,353	No	4	X	Direct
Common Stock	Acquisiton	2015-05-19	500,000	$15.88	14,005,353	No	4	X	Direct
Common Stock	Disposition	2015-05-19	2,463,123	$64.85	11,542,230	No	4	S	Direct
Common Stock	Disposition	2015-05-19	40,000	$64.85	121,699	No	4	S	Indirect	By GFEF Limited Partnership

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	X	Direct
No	4	X	Direct
No	4	S	Direct
No	4	S	Indirect	By GFEF Limited Partnership

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (Right to Buy)	Disposition	2015-05-19	500,000	$0.00	500,000	$13.06
Common Stock	Employee Stock Option (Right to Buy)	Disposition	2015-05-19	500,000	$0.00	500,000	$15.88

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2018-06-30	No	4	X	Direct
0		2018-06-30	No	4	X	Direct

Footnotes

These shares are held solely by Dr. Gillings, who is the Executive Chairman of Quintiles Transnational Holdings Inc. and a member of a group with the GFEF Limited Partnership for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, that collectively owns more than 10% of the outstanding shares of Quintiles Transnational Holdings Inc. common stock. Dr. Gillings and GFEF Limited Partnership each disclaims beneficial ownership of the shares reported in this Form 4 except to the extent of his or its pecuniary interest therein.
These shares are owned indirectly by Dr. Gillings by virtue of his position as the general partner of the GFEF Limited Partnership. Dr. Gillings disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
Options granted to Dr. Gillings under the Quintiles Transnational Holdings Inc. 2008 Stock Incentive Plan to purchase 500,000 shares of Quintiles Transnational Holdings Inc. common stock, all of which vested on June 30, 2008.